Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025

Author's Avatar
Apr 10, 2025
Article's Main Image

Summary:

  • Bionano Genomics (BNGO, Financial) forecasts significant revenue growth for 2025 with projections ranging between $29 and $32 million.
  • Analyst price target for BNGO averages at $7.00, implying a potential 66.67% upside.
  • GuruFocus projects a remarkable 8830.71% upside based on its proprietary GF Value estimation.

Bionano Genomics' Path to Revenue Growth

Bionano Genomics (BNGO) is poised for substantial revenue expansion by 2025, with expectations set between $29 and $32 million. The company is strategically focusing on boosting revenue per customer, rather than merely increasing the number of installed optical genome mapping systems. This strategy is underscored by the positive reception of the Stratus compute, which is expected to foster further growth in user numbers across the United States and Europe.

Wall Street Analysts' Price Forecasts

1910377004755218432.png

According to insights from 2 analysts, Bionano Genomics Inc (BNGO, Financial) is projected to reach an average price target of $7.00 over the next year. This forecast presents a high estimate of $10.00 and a low of $4.00, suggesting a possible upside of 66.67% from its current price of $4.20. For a more in-depth analysis, please visit the Bionano Genomics Inc (BNGO) Forecast page.

Brokerage Firm Recommendations

The consensus recommendation from 3 brokerage firms places Bionano Genomics Inc (BNGO, Financial) at an average rating of 2.7, categorizing it as a "Hold." The rating system spans from 1 to 5, where 1 indicates a Strong Buy and 5 signifies a Sell.

Analyzing GF Value Potential

According to GuruFocus, the estimated GF Value for Bionano Genomics Inc (BNGO, Financial) in one year is anticipated to be $375.09. This figure points to a staggering upside of 8830.71% from the current trading price of $4.20. The GF Value represents GuruFocus' calculation of a stock's fair value, taking into account historical trading multiples, previous business growth, and future performance estimates. For comprehensive data, refer to the Bionano Genomics Inc (BNGO) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.